Last updated on June 2019

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)


Brief description of study

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Clinical Study Identifier: NCT02876835

Find a site near you

Start Over

GSK Investigational Site

Flushing, NY United States
2.48miles
  Connect »

GSK Investigational Site

Ridgewood, NY United States
2.88miles
  Connect »

GSK Investigational Site

Laurelton, NY United States
6.26miles
  Connect »

GSK Investigational Site

New York, NY United States
6.63miles
  Connect »

GSK Investigational Site

Brooklyn, NY United States
6.79miles
  Connect »